CHASITY COOPER: Open Payments
NPI 1619652112 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 100 payments from 10 companies in 2025. Trend: 2023 $358 · 2024 $1,400 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $329 |
| ABBVIE INC. | 19 | $287 |
| E.R. Squibb & Sons, L.L.C. | 21 | $284 |
| Otsuka America Pharmaceutical, Inc. | 9 | $205 |
| Neurocrine BioSciences, Inc. | 4 | $193 |
| Alkermes, Inc. | 3 | $167 |
| Axsome Therapeutics, Inc. | 1 | $126 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, COBENFY, INGREZZA, ABILIFY MAINTENA, Auvelity, LYBALVI.
Industry payments across FL — which companies pay providers there.
